Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950

JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950

智通财经智通财经2026/10/06 04:41
Show original

JPMorgan has raised the price target for Regeneron Pharmaceuticals (REGN.US) from $900 to $950.

JPMorgan: Raises Regeneron Pharmaceuticals (REGN.US) target price from $900 to $950.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

As streaming impacts satellite radio, Sirius XM (SIRI.US) reportedly appoints digital media veteran Su De as CEO

According to sources familiar with the matter, Sirius XM (SIRI.US) plans to appoint board member Anjali Sud as its next CEO.

智通财经•2026/11/09 10:51